ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 142

Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada

C. Allyson Jones1, Pierre Guy2, Hui Xie3, Eric C. Sayre4 and Diane Lacaille5,6, 1Physical Therapy, University of Alberta, Edmonton, AB, Canada, 2Department of Orthopaedics, University of British Columbia / Centre for Hip Health and Mobility, Vancouver, BC, Canada, 3Biostatistics, Faculty of Health Sciences, Simon Fraser University / Arthritis Research Canada, Burnaby, BC, Canada, 4Arthritis Research Canada, Richmond, BC, Canada, 5Arthritis Research Canada/ University of British Columbia, Vancouver, BC, Canada, 6University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Epidemiologic methods, population studies and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hip fractures have serious long-term effects, including a high 1-year mortality rate (usually 20-30%) and poor functional recovery, with approximately 50% not attaining pre-fracture functional status. Although risk of hip fractures is known to be increased in rheumatoid arthritis (RA), few studies specifically look at the incidence of hip fractures in patients with RA compared to general population controls. We estimated the incidence of hip fractures in a population-based cohort including all incident RA cases in a Canadian province, using administrative health data.

Methods: Using physician billing data and a previously published RA definition, we assembled an incident cohort of all cases with RA onset between 1997 and 2009. Controls (with no diagnosis of RA or other inflammatory arthritis) selected randomly from the general population were matched 2:1 to RA patients on birth year, gender and index year. RA and controls with prior hip fractures, pathological fractures or Paget’s disease were excluded. Hip fractures (ICD9-CM codes 820.0, 820.2; ICD10-CA codes S72.0, S72.1, S72.2) were identified using hospitalization data (includes ≤25 codes defining reason for admission or complications during hospitalization). Crude incident rates were calculated as number of new hip fractures per person-year (PY). Cox-regression models were used to compare age and sex adjusted risk of hip fracture in RA relative to controls.

Results: A total of 60,101 RA patients and 120,462 controls (mean age 57.2 yrs; 68% females for each cohort) were followed to December 2014, yielding 0.596 million PY and 1.23 million PY, resp. Incident hip fractures were observed in 2463 RA and 3566 controls. Mean (SD) age at time of fracture was 78.9 (10.9) yrs in RA and 82.1 (9.0) yrs in controls. Crude incidence rate was 4.1 and 2.9 per 1000 PY for RA and controls, resp., yielding an incidence rate ratio (IRR) of 1.42 [95% CI 1.35, 1.50]. Crude IRRs decreased with age and did not differ by sex (Figure 1). Adjusting for age and sex, persons with RA had 48% greater risk of hip fracture than persons without (HR 1.48, 95%CI 1.41, 1.56).

Conclusion: Risk of hip fractures in persons with RA is higher than age/sex matched controls particularly at younger ages. Given the impact of hip fractures, this has important implications for functional status and quality of life of people with RA. Further work on course of recovery, mortality and health services use post-fracture is needed.


Disclosure: C. A. Jones, None; P. Guy, None; H. Xie, None; E. C. Sayre, None; D. Lacaille, None.

To cite this abstract in AMA style:

Jones CA, Guy P, Xie H, Sayre EC, Lacaille D. Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/incidence-of-hip-fracture-in-rheumatoid-arthritis-british-columbia-canada/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-hip-fracture-in-rheumatoid-arthritis-british-columbia-canada/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology